ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Granulocyte Colony-Stimulating Factor for Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-3L16184
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Human Granulocyte Colony Stimulating Factor for Injection Market Research Report 2023
BUY CHAPTERS

Global Human Granulocyte Colony-Stimulating Factor for Injection Market Research Report 2025

Code: QYRE-Auto-3L16184
Report
May 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Amgen Inc
Novartis
Dr. Reddy’s Laboratories
Qilu Pharmaceutical
CSPC Pharmaceutical Group
Jiangsu Hengrui Pharmaceuticals
Kyowa Kirin
Harbin Pharmaceutical Group
Xiamen Amoytop Biotech

Human Granulocyte Colony-Stimulating Factor for Injection Market Size

The global market for Human Granulocyte Colony-Stimulating Factor for Injection was valued at US$ 2561 million in the year 2024 and is projected to reach a revised size of US$ 3182 million by 2031, growing at a CAGR of 3.2% during the forecast period.

Human Granulocyte Colony-Stimulating Factor for Injection Market

Human Granulocyte Colony-Stimulating Factor for Injection Market

Human Granulocyte Colony-Stimulating Factor (G-CSF) for Injection is a biopharmaceutical product used to stimulate the production of white blood cells, particularly granulocytes, in the body. This medication is primarily prescribed to treat conditions that result in low white blood cell counts, such as neutropenia caused by chemotherapy, bone marrow disorders, or certain medical procedures. The market for G-CSF injections is substantial, driven by the widespread use of chemotherapy and the increasing demand for therapies that help manage associated side effects. Future developments in this field may involve enhanced formulations, improved administration methods, and broader applications in various medical contexts.
Human Granulocyte Colony-Stimulating Factor for Injection is a crucial biopharmaceutical product primarily used in the treatment of diseases like leukemia and aplastic anemia, with a steadily growing market. With the global aging population and an increasing burden of chronic illnesses, its sales continue to rise. In the future, the market is expected to expand further, potentially encompassing the treatment of more white blood cell-related conditions, and innovation in biopharmaceutical solutions is likely to drive development in this field.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Granulocyte Colony-Stimulating Factor for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Granulocyte Colony-Stimulating Factor for Injection.
The Human Granulocyte Colony-Stimulating Factor for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Granulocyte Colony-Stimulating Factor for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Granulocyte Colony-Stimulating Factor for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Granulocyte Colony-Stimulating Factor for Injection Market Report

Report Metric Details
Report Name Human Granulocyte Colony-Stimulating Factor for Injection Market
Accounted market size in year US$ 2561 million
Forecasted market size in 2031 US$ 3182 million
CAGR 3.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Amgen, Novartis, Dr.Reddy's Laboratories, Qilu Pharmaceutical, CSPC Pharmaceutical Group, Jiangsu Hengrui Pharmaceuticals, Kyowa Kirin, Harbin Pharmaceutical Group, Xiamen Amoytop Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Granulocyte Colony-Stimulating Factor for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Granulocyte Colony-Stimulating Factor for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Human Granulocyte Colony-Stimulating Factor for Injection Market growing?

Ans: The Human Granulocyte Colony-Stimulating Factor for Injection Market witnessing a CAGR of 3.2% during the forecast period 2025-2031.

What is the Human Granulocyte Colony-Stimulating Factor for Injection Market size in 2031?

Ans: The Human Granulocyte Colony-Stimulating Factor for Injection Market size in 2031 will be US$ 3182 million.

Who are the main players in the Human Granulocyte Colony-Stimulating Factor for Injection Market report?

Ans: The main players in the Human Granulocyte Colony-Stimulating Factor for Injection Market are Pfizer, Amgen, Novartis, Dr.Reddy's Laboratories, Qilu Pharmaceutical, CSPC Pharmaceutical Group, Jiangsu Hengrui Pharmaceuticals, Kyowa Kirin, Harbin Pharmaceutical Group, Xiamen Amoytop Biotech

What are the Application segmentation covered in the Human Granulocyte Colony-Stimulating Factor for Injection Market report?

Ans: The Applications covered in the Human Granulocyte Colony-Stimulating Factor for Injection Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Human Granulocyte Colony-Stimulating Factor for Injection Market report?

Ans: The Types covered in the Human Granulocyte Colony-Stimulating Factor for Injection Market report are Vial, Prefilled Syringe

Recommended Reports

Colony Stimulating Factors

Hematology & Blood Disorders

Injection Biologics

1 Human Granulocyte Colony-Stimulating Factor for Injection Market Overview
1.1 Product Definition
1.2 Human Granulocyte Colony-Stimulating Factor for Injection by Type
1.2.1 Global Human Granulocyte Colony-Stimulating Factor for Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Vial
1.2.3 Prefilled Syringe
1.3 Human Granulocyte Colony-Stimulating Factor for Injection by Application
1.3.1 Global Human Granulocyte Colony-Stimulating Factor for Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Human Granulocyte Colony-Stimulating Factor for Injection Market Size Estimates and Forecasts
1.4.1 Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue 2020-2031
1.4.2 Global Human Granulocyte Colony-Stimulating Factor for Injection Sales 2020-2031
1.4.3 Global Human Granulocyte Colony-Stimulating Factor for Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Granulocyte Colony-Stimulating Factor for Injection Market Competition by Manufacturers
2.1 Global Human Granulocyte Colony-Stimulating Factor for Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Granulocyte Colony-Stimulating Factor for Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Granulocyte Colony-Stimulating Factor for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Granulocyte Colony-Stimulating Factor for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Granulocyte Colony-Stimulating Factor for Injection, Product Type & Application
2.7 Global Key Manufacturers of Human Granulocyte Colony-Stimulating Factor for Injection, Date of Enter into This Industry
2.8 Global Human Granulocyte Colony-Stimulating Factor for Injection Market Competitive Situation and Trends
2.8.1 Global Human Granulocyte Colony-Stimulating Factor for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Granulocyte Colony-Stimulating Factor for Injection Players Market Share by Revenue
2.8.3 Global Human Granulocyte Colony-Stimulating Factor for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Granulocyte Colony-Stimulating Factor for Injection Market Scenario by Region
3.1 Global Human Granulocyte Colony-Stimulating Factor for Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Granulocyte Colony-Stimulating Factor for Injection Sales by Region: 2020-2031
3.2.1 Global Human Granulocyte Colony-Stimulating Factor for Injection Sales by Region: 2020-2025
3.2.2 Global Human Granulocyte Colony-Stimulating Factor for Injection Sales by Region: 2026-2031
3.3 Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Region: 2020-2031
3.3.1 Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Region: 2020-2025
3.3.2 Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Region: 2026-2031
3.4 North America Human Granulocyte Colony-Stimulating Factor for Injection Market Facts & Figures by Country
3.4.1 North America Human Granulocyte Colony-Stimulating Factor for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Granulocyte Colony-Stimulating Factor for Injection Sales by Country (2020-2031)
3.4.3 North America Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Granulocyte Colony-Stimulating Factor for Injection Market Facts & Figures by Country
3.5.1 Europe Human Granulocyte Colony-Stimulating Factor for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Granulocyte Colony-Stimulating Factor for Injection Sales by Country (2020-2031)
3.5.3 Europe Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Granulocyte Colony-Stimulating Factor for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Human Granulocyte Colony-Stimulating Factor for Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Granulocyte Colony-Stimulating Factor for Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Granulocyte Colony-Stimulating Factor for Injection Market Facts & Figures by Country
3.7.1 Latin America Human Granulocyte Colony-Stimulating Factor for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Granulocyte Colony-Stimulating Factor for Injection Sales by Country (2020-2031)
3.7.3 Latin America Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Granulocyte Colony-Stimulating Factor for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Granulocyte Colony-Stimulating Factor for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Granulocyte Colony-Stimulating Factor for Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Granulocyte Colony-Stimulating Factor for Injection Sales by Type (2020-2031)
4.1.1 Global Human Granulocyte Colony-Stimulating Factor for Injection Sales by Type (2020-2025)
4.1.2 Global Human Granulocyte Colony-Stimulating Factor for Injection Sales by Type (2026-2031)
4.1.3 Global Human Granulocyte Colony-Stimulating Factor for Injection Sales Market Share by Type (2020-2031)
4.2 Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Type (2020-2031)
4.2.1 Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Type (2020-2025)
4.2.2 Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Type (2026-2031)
4.2.3 Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue Market Share by Type (2020-2031)
4.3 Global Human Granulocyte Colony-Stimulating Factor for Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Granulocyte Colony-Stimulating Factor for Injection Sales by Application (2020-2031)
5.1.1 Global Human Granulocyte Colony-Stimulating Factor for Injection Sales by Application (2020-2025)
5.1.2 Global Human Granulocyte Colony-Stimulating Factor for Injection Sales by Application (2026-2031)
5.1.3 Global Human Granulocyte Colony-Stimulating Factor for Injection Sales Market Share by Application (2020-2031)
5.2 Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Application (2020-2031)
5.2.1 Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Application (2020-2025)
5.2.2 Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Application (2026-2031)
5.2.3 Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue Market Share by Application (2020-2031)
5.3 Global Human Granulocyte Colony-Stimulating Factor for Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Human Granulocyte Colony-Stimulating Factor for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Human Granulocyte Colony-Stimulating Factor for Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Company Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Human Granulocyte Colony-Stimulating Factor for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amgen Human Granulocyte Colony-Stimulating Factor for Injection Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Human Granulocyte Colony-Stimulating Factor for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis Human Granulocyte Colony-Stimulating Factor for Injection Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Dr.Reddy's Laboratories
6.4.1 Dr.Reddy's Laboratories Company Information
6.4.2 Dr.Reddy's Laboratories Description and Business Overview
6.4.3 Dr.Reddy's Laboratories Human Granulocyte Colony-Stimulating Factor for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Dr.Reddy's Laboratories Human Granulocyte Colony-Stimulating Factor for Injection Product Portfolio
6.4.5 Dr.Reddy's Laboratories Recent Developments/Updates
6.5 Qilu Pharmaceutical
6.5.1 Qilu Pharmaceutical Company Information
6.5.2 Qilu Pharmaceutical Description and Business Overview
6.5.3 Qilu Pharmaceutical Human Granulocyte Colony-Stimulating Factor for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Qilu Pharmaceutical Human Granulocyte Colony-Stimulating Factor for Injection Product Portfolio
6.5.5 Qilu Pharmaceutical Recent Developments/Updates
6.6 CSPC Pharmaceutical Group
6.6.1 CSPC Pharmaceutical Group Company Information
6.6.2 CSPC Pharmaceutical Group Description and Business Overview
6.6.3 CSPC Pharmaceutical Group Human Granulocyte Colony-Stimulating Factor for Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CSPC Pharmaceutical Group Human Granulocyte Colony-Stimulating Factor for Injection Product Portfolio
6.6.5 CSPC Pharmaceutical Group Recent Developments/Updates
6.7 Jiangsu Hengrui Pharmaceuticals
6.7.1 Jiangsu Hengrui Pharmaceuticals Company Information
6.7.2 Jiangsu Hengrui Pharmaceuticals Description and Business Overview
6.7.3 Jiangsu Hengrui Pharmaceuticals Human Granulocyte Colony-Stimulating Factor for Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Jiangsu Hengrui Pharmaceuticals Human Granulocyte Colony-Stimulating Factor for Injection Product Portfolio
6.7.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
6.8 Kyowa Kirin
6.8.1 Kyowa Kirin Company Information
6.8.2 Kyowa Kirin Description and Business Overview
6.8.3 Kyowa Kirin Human Granulocyte Colony-Stimulating Factor for Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Kyowa Kirin Human Granulocyte Colony-Stimulating Factor for Injection Product Portfolio
6.8.5 Kyowa Kirin Recent Developments/Updates
6.9 Harbin Pharmaceutical Group
6.9.1 Harbin Pharmaceutical Group Company Information
6.9.2 Harbin Pharmaceutical Group Description and Business Overview
6.9.3 Harbin Pharmaceutical Group Human Granulocyte Colony-Stimulating Factor for Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Harbin Pharmaceutical Group Human Granulocyte Colony-Stimulating Factor for Injection Product Portfolio
6.9.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.10 Xiamen Amoytop Biotech
6.10.1 Xiamen Amoytop Biotech Company Information
6.10.2 Xiamen Amoytop Biotech Description and Business Overview
6.10.3 Xiamen Amoytop Biotech Human Granulocyte Colony-Stimulating Factor for Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Xiamen Amoytop Biotech Human Granulocyte Colony-Stimulating Factor for Injection Product Portfolio
6.10.5 Xiamen Amoytop Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Granulocyte Colony-Stimulating Factor for Injection Industry Chain Analysis
7.2 Human Granulocyte Colony-Stimulating Factor for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Granulocyte Colony-Stimulating Factor for Injection Production Mode & Process Analysis
7.4 Human Granulocyte Colony-Stimulating Factor for Injection Sales and Marketing
7.4.1 Human Granulocyte Colony-Stimulating Factor for Injection Sales Channels
7.4.2 Human Granulocyte Colony-Stimulating Factor for Injection Distributors
7.5 Human Granulocyte Colony-Stimulating Factor for Injection Customer Analysis
8 Human Granulocyte Colony-Stimulating Factor for Injection Market Dynamics
8.1 Human Granulocyte Colony-Stimulating Factor for Injection Industry Trends
8.2 Human Granulocyte Colony-Stimulating Factor for Injection Market Drivers
8.3 Human Granulocyte Colony-Stimulating Factor for Injection Market Challenges
8.4 Human Granulocyte Colony-Stimulating Factor for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Amgen Inc
Novartis
Dr. Reddy’s Laboratories
Qilu Pharmaceutical
CSPC Pharmaceutical Group
Jiangsu Hengrui Pharmaceuticals
Kyowa Kirin
Harbin Pharmaceutical Group
Xiamen Amoytop Biotech
List of Tables
 Table 1. Global Human Granulocyte Colony-Stimulating Factor for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Human Granulocyte Colony-Stimulating Factor for Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Human Granulocyte Colony-Stimulating Factor for Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Human Granulocyte Colony-Stimulating Factor for Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Human Granulocyte Colony-Stimulating Factor for Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Human Granulocyte Colony-Stimulating Factor for Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Human Granulocyte Colony-Stimulating Factor for Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Human Granulocyte Colony-Stimulating Factor for Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Human Granulocyte Colony-Stimulating Factor for Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Human Granulocyte Colony-Stimulating Factor for Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Granulocyte Colony-Stimulating Factor for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Granulocyte Colony-Stimulating Factor for Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Granulocyte Colony-Stimulating Factor for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Human Granulocyte Colony-Stimulating Factor for Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Human Granulocyte Colony-Stimulating Factor for Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Human Granulocyte Colony-Stimulating Factor for Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Human Granulocyte Colony-Stimulating Factor for Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Human Granulocyte Colony-Stimulating Factor for Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Human Granulocyte Colony-Stimulating Factor for Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Human Granulocyte Colony-Stimulating Factor for Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Human Granulocyte Colony-Stimulating Factor for Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Human Granulocyte Colony-Stimulating Factor for Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Human Granulocyte Colony-Stimulating Factor for Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Human Granulocyte Colony-Stimulating Factor for Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Human Granulocyte Colony-Stimulating Factor for Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Human Granulocyte Colony-Stimulating Factor for Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Human Granulocyte Colony-Stimulating Factor for Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Human Granulocyte Colony-Stimulating Factor for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Human Granulocyte Colony-Stimulating Factor for Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Human Granulocyte Colony-Stimulating Factor for Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Human Granulocyte Colony-Stimulating Factor for Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Human Granulocyte Colony-Stimulating Factor for Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Human Granulocyte Colony-Stimulating Factor for Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Human Granulocyte Colony-Stimulating Factor for Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Human Granulocyte Colony-Stimulating Factor for Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Human Granulocyte Colony-Stimulating Factor for Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Human Granulocyte Colony-Stimulating Factor for Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Human Granulocyte Colony-Stimulating Factor for Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Human Granulocyte Colony-Stimulating Factor for Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Human Granulocyte Colony-Stimulating Factor for Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Human Granulocyte Colony-Stimulating Factor for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Human Granulocyte Colony-Stimulating Factor for Injection Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Amgen Company Information
 Table 76. Amgen Description and Business Overview
 Table 77. Amgen Human Granulocyte Colony-Stimulating Factor for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Amgen Human Granulocyte Colony-Stimulating Factor for Injection Product
 Table 79. Amgen Recent Developments/Updates
 Table 80. Novartis Company Information
 Table 81. Novartis Description and Business Overview
 Table 82. Novartis Human Granulocyte Colony-Stimulating Factor for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Novartis Human Granulocyte Colony-Stimulating Factor for Injection Product
 Table 84. Novartis Recent Developments/Updates
 Table 85. Dr.Reddy's Laboratories Company Information
 Table 86. Dr.Reddy's Laboratories Description and Business Overview
 Table 87. Dr.Reddy's Laboratories Human Granulocyte Colony-Stimulating Factor for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Dr.Reddy's Laboratories Human Granulocyte Colony-Stimulating Factor for Injection Product
 Table 89. Dr.Reddy's Laboratories Recent Developments/Updates
 Table 90. Qilu Pharmaceutical Company Information
 Table 91. Qilu Pharmaceutical Description and Business Overview
 Table 92. Qilu Pharmaceutical Human Granulocyte Colony-Stimulating Factor for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Qilu Pharmaceutical Human Granulocyte Colony-Stimulating Factor for Injection Product
 Table 94. Qilu Pharmaceutical Recent Developments/Updates
 Table 95. CSPC Pharmaceutical Group Company Information
 Table 96. CSPC Pharmaceutical Group Description and Business Overview
 Table 97. CSPC Pharmaceutical Group Human Granulocyte Colony-Stimulating Factor for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. CSPC Pharmaceutical Group Human Granulocyte Colony-Stimulating Factor for Injection Product
 Table 99. CSPC Pharmaceutical Group Recent Developments/Updates
 Table 100. Jiangsu Hengrui Pharmaceuticals Company Information
 Table 101. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
 Table 102. Jiangsu Hengrui Pharmaceuticals Human Granulocyte Colony-Stimulating Factor for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Jiangsu Hengrui Pharmaceuticals Human Granulocyte Colony-Stimulating Factor for Injection Product
 Table 104. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
 Table 105. Kyowa Kirin Company Information
 Table 106. Kyowa Kirin Description and Business Overview
 Table 107. Kyowa Kirin Human Granulocyte Colony-Stimulating Factor for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Kyowa Kirin Human Granulocyte Colony-Stimulating Factor for Injection Product
 Table 109. Kyowa Kirin Recent Developments/Updates
 Table 110. Harbin Pharmaceutical Group Company Information
 Table 111. Harbin Pharmaceutical Group Description and Business Overview
 Table 112. Harbin Pharmaceutical Group Human Granulocyte Colony-Stimulating Factor for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Harbin Pharmaceutical Group Human Granulocyte Colony-Stimulating Factor for Injection Product
 Table 114. Harbin Pharmaceutical Group Recent Developments/Updates
 Table 115. Xiamen Amoytop Biotech Company Information
 Table 116. Xiamen Amoytop Biotech Description and Business Overview
 Table 117. Xiamen Amoytop Biotech Human Granulocyte Colony-Stimulating Factor for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Xiamen Amoytop Biotech Human Granulocyte Colony-Stimulating Factor for Injection Product
 Table 119. Xiamen Amoytop Biotech Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Human Granulocyte Colony-Stimulating Factor for Injection Distributors List
 Table 123. Human Granulocyte Colony-Stimulating Factor for Injection Customers List
 Table 124. Human Granulocyte Colony-Stimulating Factor for Injection Market Trends
 Table 125. Human Granulocyte Colony-Stimulating Factor for Injection Market Drivers
 Table 126. Human Granulocyte Colony-Stimulating Factor for Injection Market Challenges
 Table 127. Human Granulocyte Colony-Stimulating Factor for Injection Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Granulocyte Colony-Stimulating Factor for Injection
 Figure 2. Global Human Granulocyte Colony-Stimulating Factor for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human Granulocyte Colony-Stimulating Factor for Injection Market Share by Type: 2024 & 2031
 Figure 4. Vial Product Picture
 Figure 5. Prefilled Syringe Product Picture
 Figure 6. Global Human Granulocyte Colony-Stimulating Factor for Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Human Granulocyte Colony-Stimulating Factor for Injection Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Others
 Figure 11. Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Human Granulocyte Colony-Stimulating Factor for Injection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Human Granulocyte Colony-Stimulating Factor for Injection Sales (2020-2031) & (K Units)
 Figure 14. Global Human Granulocyte Colony-Stimulating Factor for Injection Average Price (US$/Unit) & (2020-2031)
 Figure 15. Human Granulocyte Colony-Stimulating Factor for Injection Report Years Considered
 Figure 16. Human Granulocyte Colony-Stimulating Factor for Injection Sales Share by Manufacturers in 2024
 Figure 17. Global Human Granulocyte Colony-Stimulating Factor for Injection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Human Granulocyte Colony-Stimulating Factor for Injection Players: Market Share by Revenue in Human Granulocyte Colony-Stimulating Factor for Injection in 2024
 Figure 19. Human Granulocyte Colony-Stimulating Factor for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Human Granulocyte Colony-Stimulating Factor for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Human Granulocyte Colony-Stimulating Factor for Injection Sales Market Share by Country (2020-2031)
 Figure 22. North America Human Granulocyte Colony-Stimulating Factor for Injection Revenue Market Share by Country (2020-2031)
 Figure 23. United States Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Human Granulocyte Colony-Stimulating Factor for Injection Sales Market Share by Country (2020-2031)
 Figure 26. Europe Human Granulocyte Colony-Stimulating Factor for Injection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Human Granulocyte Colony-Stimulating Factor for Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Human Granulocyte Colony-Stimulating Factor for Injection Revenue Market Share by Region (2020-2031)
 Figure 34. China Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Human Granulocyte Colony-Stimulating Factor for Injection Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Human Granulocyte Colony-Stimulating Factor for Injection Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Human Granulocyte Colony-Stimulating Factor for Injection Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Human Granulocyte Colony-Stimulating Factor for Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Human Granulocyte Colony-Stimulating Factor for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Human Granulocyte Colony-Stimulating Factor for Injection by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Human Granulocyte Colony-Stimulating Factor for Injection by Type (2020-2031)
 Figure 53. Global Human Granulocyte Colony-Stimulating Factor for Injection Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Human Granulocyte Colony-Stimulating Factor for Injection by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Human Granulocyte Colony-Stimulating Factor for Injection by Application (2020-2031)
 Figure 56. Global Human Granulocyte Colony-Stimulating Factor for Injection Price (US$/Unit) by Application (2020-2031)
 Figure 57. Human Granulocyte Colony-Stimulating Factor for Injection Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Recombinant Human GM CSF for Injection Market Research Report 2024
Granulocyte Colony Stimulating Factor G CSF Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Granulocyte Colony Stimulating Market Insights Forecast to 2030
Global Human Granulocyte Macrophage Colony stimulating Factor for Injection Market Research Report 2024
Global Granulocyte Colony Stimulating Factor G CSF Market Research Report 2024
Global Recombinant Human Granulocyte Colony Stimulating Factor Injection rhG CSF Market Research Report 2025
Global Filgrastim Injection Market Research Report 2024
Global Granulocyte Colony stimulating Factor G CSF ELISA Kit Market Research Report 2024
Global Long acting Granulocyte Colony Stimulating Factor G CSF Market Research Report 2024
Global Pegfilgrastim Market Insights Forecast to 2030
Global Granulocyte Macrophage Colony Stimulating Factor GM CSF Market Research Report 2024
Global PEGylated Granulocyte Colony Stimulating Factor Market Research Report 2024
Global Macrophage Colony Stimulating Factor Reagent Market Research Report 2025
Global Recombinant Human M CSF Protein Market Research Report 2025
Global Filgrastim Market Insights Forecast to 2030
Global Granulocyte Macrophage Colony Stimulating Factor GM CSF ELISA Kit Market Research Report 2024
Pegfilgrastim Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PEG rhG CSF Market Research Report 2025
Neulasta Pegfilgrastim and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chemotherapy Induced Neutropenia CIN Drug Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions